Abstract
COVID-19 is a severe global problem that has crippled many industries and killed many people around the world. One of the primary ways to decrease the casualties is the infected person’s identification at the proper time. AI can play a significant role in these cases by monitoring and detecting infected persons in early-stage so that it can help many organizations. In this paper, we aim to propose a fully-automated method to detect COVID-19 from the patient’s CT scan without needing a clinical technician. We introduce a new dataset that contains 48260 CT scan images from 282 normal persons and 15589 images from 95 patients with COVID-19 infection. Our proposed network takes all the CT scan image sequences of a patient as the input and determines if the patient is infected with COVID-19. At the first stage, this network runs an image processing algorithm to discard those CT images that inside the lung is not properly visible in them. This helps to reduce the number of images that shall be identified as normal or COVID-19, so it reduces the processing time. Also, running this algorithm makes the deep network at the next stage to analyze only the proper images and thus reduces false detections. At the next stage, we propose a modified version of ResNet50V2 that is enhanced by a feature pyramid network for classifying the selected CT images into COVID-19 or normal. If enough number of chosen CT scan images of a patient be identified as COVID-19, the network considers that patient, infected to this disease. The ResNet50V2 with feature pyramid network achieved 98.49% accuracy on more than 7996 validation images and correctly identified almost 237 patients from 245 patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We did not receive any foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We declare that this paper is original and has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that all have approved the order of authors listed in the paper of us. All the patients' shared data have been approved by Negin Radiology Medical Center located at Sari, Iran, under the supervision of its director(Dr.Sakhaei, radiology specialist) and Dr.Mahdi Hassanzadeh. It must be mentioned that to protect patients' privacy, all the DICOM files have been converted to TIFF format files to remove the patients' information. Dr.Mahdi Hassanzadeh email : mehdi.hasanzadeh.1363{at}gmail.com
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
attar.abolfazl{at}ee.sharif.edu, yaghobsakhaei{at}yahoo.com
Data Availability
Data and Codes are available at: https://github.com/mr7495/COVID-CT-Code https://github.com/mr7495/COVID-CTset
